celecoxib has been researched along with Esophageal Diseases in 1 studies
Esophageal Diseases: Pathological processes in the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with celecoxib significantly delayed esophageal ulcer healing and suppressed ulceration-triggered increases in esophageal epithelial cell proliferation, c-Met mRNA and protein expression, and ERK2 activity." | 1.31 | Selective cyclooxygenase-2 blocker delays healing of esophageal ulcers in rats and inhibits ulceration-triggered c-Met/hepatocyte growth factor receptor induction and extracellular signal-regulated kinase 2 activation. ( Baatar, D; Jones, MK; Kawanaka, H; Kitano, S; Moon, WS; Pai, R; Szabo, IL; Tarnawski, AS, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baatar, D | 1 |
| Jones, MK | 1 |
| Pai, R | 1 |
| Kawanaka, H | 1 |
| Szabo, IL | 1 |
| Moon, WS | 1 |
| Kitano, S | 1 |
| Tarnawski, AS | 1 |
1 other study available for celecoxib and Esophageal Diseases
| Article | Year |
|---|---|
Selective cyclooxygenase-2 blocker delays healing of esophageal ulcers in rats and inhibits ulceration-triggered c-Met/hepatocyte growth factor receptor induction and extracellular signal-regulated kinase 2 activation.
Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Down-R | 2002 |